Senate Finance Committee Republicans said Wednesday (July 17) that their support for drug-pricing legislation depends in large part on whether it would significantly reduce costs for Medicare beneficiaries, and Congressional Budget Office staff didn’t yet have hard numbers on the beneficiary impact when they met with Finance GOP members Wednesday morning. However, the informal analysis by CBO indicates the bill would reduce government spending. CBO staff presented Finance GOP members with what Sen. John Thune (R-SD) called “observations,” and not...